Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001725663-26-000002

Chief Financial Officer sold 7,988 shares at $12.25 ($97,892)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2026-03-04 Sale 10b5-1 −7,988 $12.25 $97,892 137,987 D
Open-market sales · 7,988 sh · avg $12.25 · $97,892
Loading xslF345X05/wk-form4_1772833002.xml…